Cellular composition of tumor lymph nodes from Roquinsan/+ mice. Frequency of cellular subsets as measured by flow cytometry. (A) Lymphocyte composition of tumor (Tm) and nontumor (nTm) lymph nodes from Roquinsan/+ and Roquin+/+mice. (B-C) Percentage of TFH (CD4+PD-1hiCXCR5+) and GC B (B220+FAS+GL7hi) cells in enlarged (tumor) and nonenlarged (normal) lymph nodes from Roquinsan/+ mice compared with control Roquinsan/+ and Roquin+/+mice. (D) Representative FACS plots showing the percentage of TFH based on CD4+PD-1hiBcl-6+ cells in tumor, nontumor lymph nodes compared with normal Roquinsan/+ mice. (E-F) Comparison of TFH cells (CD4+PD-1hiBcl-6+), frequency (as %CD4+), and total numbers in tumor and contralateral nontumor lymph nodes compared with lymph nodes from normal Roquinsan/+ mice. (G-H) Proportions of TFH (G) and GC B cells (H) undergoing proliferation, as indicated by expression of Ki-67. Histograms in all panels show the mean with SEM (A) or median (B-H) values of 2 to 10 mice 26 to 40 weeks of age. Results are representative of at least 2 independent experiments. ns indicates not significant. *P < .05; **P < .01; ***P < .001.